©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessMaple syrup urine disease, differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for Maple syrup urine disease comprising 7 guideline-curated or altogether 30 curated genes according to the clinical signs

ID
AP3929
Number of genes
30 Accredited laboratory test
Examined sequence length
5,5 kb (Core-/Core-canditate-Genes)
43,9 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
BCKDHA1338NM_000709.4AR
BCKDHB1179NM_000056.5AR
DBT1449NM_001918.5AR
DLD1530NM_000108.5AR
ACAT11284NM_000019.4AR
AMT1212NM_000481.4AR
ARG1969NM_000045.4AR
ASL1395NM_000048.4AR
ASS11239NM_000050.4AR
CA5A918NM_001739.2AR
CPS14503NM_001122633.3AR
FAH1260NM_000137.4AR
GALT1140NM_000155.4AR
GCSH522NM_004483.5AR
GLDC3063NM_000170.3AR
GLUD11677NM_005271.5AD
IVD1182NM_001159508.3AR
MCEE531NM_032601.4AR
MMAA1257NM_172250.3AR
MMAB753NM_052845.4AR
MMADHC891NM_015702.3AR
MMUT2253NM_000255.4AR
NAGS1605NM_153006.3AR
OAT1320NM_000274.4AR
OTC1065NM_000531.6XLR
PCCA2187NM_000282.4AR
PCCB1620NM_000532.5AR
SLC25A132031NM_001160210.2AR
SLC25A15906NM_014252.4AR
SLC7A71536NM_001126105.3AR

Informations about the disease

Synonyms
  • Alias: Alpha-Ketosäuredecarboxylase-Mangel
  • Alias: BCKD deficiency
  • Alias: BCKD-Mangel
  • Alias: BCKDH-Mangel
  • Alias: Branched-chain 2-ketoacid dehydrogenase deficiency
  • Alias: Branched-chain alpha-keto acid dehydrogenase deficiency
  • Alias: Branched-chain ketoaciduria
  • Alias: Ketoacidemia
  • Alias: Verzweigtkettenketoazidurie
  • Allelic: Pulmonary hypertension, neonatal, susceptibility to (CPS1)
  • Alpha-methylacetoacetic aciduria (ACAT1)
  • Argininemia (ARG1)
  • Argininosuccinic aciduria (ASL)
  • Carbamoylphosphate synthetase I deficiency (CPS1)
  • Citrullinemia (ASS1)
  • Citrullinemia, adult-onset type II (SLC25A13)
  • Citrullinemia, type II, neonatal-onset (SLC25A13)
  • Dihydrolipoamide dehydrogenase deficiency (DLD)
  • Galactosemia (GALT)
  • Glycine encephalopathy (AMT, GCSH, GLDC)
  • Gyrate atrophy of choroid + retina with/-out ornithinemia (OAT)
  • Homocystinuria, cblD type, variant 1 (MMADHC)
  • Hyperammonemia due to carbonic anhydrase VA deficiency (CA5A)
  • Hyperinsulinism-hyperammonemia syndrome (GLUD1)
  • Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome (SLC25A15)
  • Isovaleric acidemia (IVD)
  • Lysinuric protein intolerance (SLC7A7)
  • Maple syrup urine disease, type II (DBT)
  • Maple syrup urine disease, type Ia (BCKDHA)
  • Maple syrup urine disease, type Ib (BCKDHB)
  • Methylmalonic aciduria + homocystinuria, cblD type (MMADHC)
  • Methylmalonic aciduria, cblD type, variant 2 (MMADHC)
  • Methylmalonic aciduria, mut(0) type (MMUT)
  • Methylmalonic aciduria, vitamin B12-responsive, cblA type (MMAA)
  • Methylmalonic aciduria, vitamin B12-responsive, cblB type (MMAB)
  • Methylmalonyl-CoA epimerase deficiency (MCEE)
  • N-acetylglutamate synthase deficiency (NAGS)
  • Ornithine transcarbamylase deficiency (OTC)
  • Propionicacidemia (PCCA, PCCB)
  • Tyrosinemia, type I (FAH)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XLR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined